Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christiane Markwardt"'
Autor:
Matthias Gutekunst, Moshe Oren, Andrea Weilbacher, Michael A Dengler, Christiane Markwardt, Jürgen Thomale, Walter E Aulitzky, Heiko van der Kuip
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e19198 (2011)
Consistent with the excellent clinical results in testicular germ cell tumors (TGCT), most cell lines derived from this cancer show an exquisite sensitivity to Cisplatin. It is well accepted that the high susceptibility of TGCT cells to apoptosis pla
Externí odkaz:
https://doaj.org/article/d9bbc01efa604c64b1b9b1ebff4bb7ea
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Imatinib is highly effective in inducing remission in chronic myelogenous leukemia (CML). However, complete eradication of the malignant clone by imatinib is rare. We investigated the efficacy of combining imatinib with cisplatin. Inhibition of Bcr-A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40fa57d1328c79507027970ef4de6393
https://doi.org/10.1158/0008-5472.c.6499484.v1
https://doi.org/10.1158/0008-5472.c.6499484.v1
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Supplementary Figure 3 from Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dd2674f8a5f2e3e4444091ade231a8f
https://doi.org/10.1158/0008-5472.22380179
https://doi.org/10.1158/0008-5472.22380179
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Supplementary Figure 1 from Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8bc5c7ef3500348da4e4a452b0f7d36
https://doi.org/10.1158/0008-5472.22380185.v1
https://doi.org/10.1158/0008-5472.22380185.v1
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Supplementary Figures 1-3 from Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d11b88f6e66462065081e6dd38140c4
https://doi.org/10.1158/0008-5472.22380176
https://doi.org/10.1158/0008-5472.22380176
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Supplementary Figure 2 from Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1116d93f065f94e79b01392a2877a46e
https://doi.org/10.1158/0008-5472.22380182.v1
https://doi.org/10.1158/0008-5472.22380182.v1
Autor:
Walter E. Aulitzky, Christiane Markwardt, Matthias Gutekunst, Heiko van der Kuip, Moshe Oren, Ioanna Skorta
Publikováno v:
Cancer research. 69(24)
Imatinib is highly effective in inducing remission in chronic myelogenous leukemia (CML). However, complete eradication of the malignant clone by imatinib is rare. We investigated the efficacy of combining imatinib with cisplatin. Inhibition of Bcr-A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fec2ed3dae3eba6a2d1f0e29cd507a4
https://pubmed.ncbi.nlm.nih.gov/19934315
https://pubmed.ncbi.nlm.nih.gov/19934315
Autor:
Christiane Markwardt, Heiko van der Kuip, Andrea Weilbacher, Jürgen Thomale, Michael A. Dengler, Moshe Oren, Matthias Gutekunst, Walter E. Aulitzky
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e19198 (2011)
PLoS ONE
PLoS ONE
Consistent with the excellent clinical results in testicular germ cell tumors (TGCT), most cell lines derived from this cancer show an exquisite sensitivity to Cisplatin. It is well accepted that the high susceptibility of TGCT cells to apoptosis pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b22a6f3dc84293c67dad76a702815e6
https://doi.org/10.1371/journal.pone.0019198
https://doi.org/10.1371/journal.pone.0019198